ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.807,51
0,07%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Exagen Inc (XGN)

  7. Exagen Inc (XGN) News

XGN

Exagen (XGN)

Exagen Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XGN
DatumZeitQuelleÜberschriftSymbolFirma
13/01/202514h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
12/01/202518h00GlobeNewswire Inc.Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial ResultsNASDAQ:XGNExagen Inc
12/12/202423h00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XGNExagen Inc
12/12/202415h00GlobeNewswire Inc.Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTDNASDAQ:XGNExagen Inc
27/11/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
20/11/202401h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
19/11/202400h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
14/11/202422h30GlobeNewswire Inc.Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD PlatformNASDAQ:XGNExagen Inc
13/11/202422h05GlobeNewswire Inc.Exagen Inc. to Participate in Fourth Quarter Investor ConferencesNASDAQ:XGNExagen Inc
12/11/202414h00GlobeNewswire Inc.Exagen Inc. Reports Third Quarter 2024 ResultsNASDAQ:XGNExagen Inc
29/10/202421h05GlobeNewswire Inc.Exagen to Announce Third Quarter 2024 Results on November 12, 2024NASDAQ:XGNExagen Inc
21/10/202422h05GlobeNewswire Inc.Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology ConvergenceNASDAQ:XGNExagen Inc
08/10/202422h39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
05/09/202400h12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XGNExagen Inc
05/09/202400h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
04/09/202422h05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:XGNExagen Inc
09/08/202423h08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
05/08/202415h15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
05/08/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
05/08/202414h00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceNASDAQ:XGNExagen Inc
02/08/202423h20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XGNExagen Inc
02/08/202415h00GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:XGNExagen Inc
02/08/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
01/08/202415h00GlobeNewswire Inc.Exagen Appoints Jeffrey G. Black as New Chief Financial OfficerNASDAQ:XGNExagen Inc
22/07/202415h00GlobeNewswire Inc.Exagen to Announce Second Quarter 2024 Results on August 5, 2024NASDAQ:XGNExagen Inc
12/06/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
12/06/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
12/06/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
11/06/202422h08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
17/05/202402h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
 Showing the most relevant articles for your search:NASDAQ:XGN

Kürzlich von Ihnen besucht

DBI
TDXP
Tec DAX
TG
DTE
Deutsche Telekom
AMEX
XLE
Energy Select Sector SPDR
TG
MBG
MercedesBenz
TG
432
Arbor Metals
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
TG
LHA
Deutsche Lufthansa
TG
NOV
Novo Nordisk
PM
XAUUSD
Gold vs US Dollar
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten